SCIENTIFIC PUBLICATIONS

Article: Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study. DOWNLOAD

PRESENTATIONS

To Be Updated Soon

PR MATERIALS

LEGATO Newsletter December 2023 DOWNLOAD

LEGATO Newsletter May 2024 DOWNLOAD

PROJECT DELIVERABLES

To Be Updated Soon